Dual Action Worming Tablets for Cats

Country: United Kingdom

Bahasa: Inggeris

Sumber: VMD (Veterinary Medicines Directorate)

Bahan aktif:

Dichlorophen, Piperazine Citrate

Boleh didapati daripada:

Battle, Hayward & Bower Ltd

Kod ATC:

QP52AG01

INN (Nama Antarabangsa):

Dichlorophen, Piperazine Citrate

Borang farmaseutikal:

Tablet

Jenis preskripsi:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Kumpulan terapeutik:

Cats

Kawasan terapeutik:

Anthelmintic

Status kebenaran:

Expired

Tarikh kebenaran:

1995-12-13

Ciri produk

Revised: 14
th
January 2009
AN: 02297/2007
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Dual Action Worming Tablets for Cats
2. QUALITATIVE AND QUANTIITATIVE COMPOSITION
Each roundworm tablet contains:
ACTIVE SUBSTANCE(S) MG
Piperazine Citrate BP
500
Each tapeworm tablet contains:
ACTIVE SUBSTANCE MG
Dichlorophen
500
EXCIPIENTS
Amaranth (E123)
0.055
For a full list of excipients see section 6.1
3. PHARMACEUTICAL FORM.
Tablet
Roundworm- circular, biconvex, white tablets engraved on one side with
a breakline
Tapeworm- circular, biconvex, pink tablets engraved on one side with a
breakline.
4. CLINICAL PARTICULARS.
4.1 TARGET SPECIES;
Cats and Kittens
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES;
For the treatment of roundworms (Ascarids) and tapeworms in cats and
kittens over 6
months old.
4.3 CONTRA INDICATION;
Do not give Roundworm tablets and Tapeworm tablets on the same day.
Do not repeat the treatment if vomiting occurs shortly after dosing.
Do not administer to animals weighing less than 1.25Kg or under 6
months of age.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES;
Cats are particularly susceptible to CNS side effects of phenols which
include
vomiting, depression and incoordination.
Revised: 14
th
January 2009
AN: 02297/2007
4.5 SPECIAL PRECAUTIONS FOR USE INCLUDING SPECIAL PRECAUTIONS TO BE
TAKEN BY THE
PERSON ADMINISTERING THE MEDICINAL PRODUCT TO THE ANIMALS;
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Consult a veterinary surgeon before dosing animals with a history of
epilepsy
or severe renal dysfunction.
Do not use if your pet is sick or recovering from an illness
It is important to establish the bodyweight of the animal accurately
before
treatment to ensure correct dosage administration.
Animals weighing less than 1.25Kg should be treated with a suitable
product
authorised for this purpose.
Do not exceed the recommended dosage.
II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
MEDICINAL PRODUCT TO ANIMALS
Ingredients in this product are known to